Detailed information for compound 1746051

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 752.938 | Formula: C37H64N6O10
  • H donors: 9 H acceptors: 10 LogP: 3.42 Rotable bonds: 26
    Rule of 5 violations (Lipinski): 3
  • SMILES: OC[C@@H](C(=O)N[C@H](C(=O)N)CC(C)C)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C(C1CCCCC1)C1CCCCC1)CC(C)C)CC(=O)O
  • InChi: 1S/C37H64N6O10/c1-20(2)16-25(32(38)48)39-35(51)28(19-44)42-37(53)31(22(5)45)43-34(50)27(18-29(46)47)40-33(49)26(17-21(3)4)41-36(52)30(23-12-8-6-9-13-23)24-14-10-7-11-15-24/h20-28,30-31,44-45H,6-19H2,1-5H3,(H2,38,48)(H,39,51)(H,40,49)(H,41,52)(H,42,53)(H,43,50)(H,46,47)/t22-,25+,26+,27+,28+,31+/m1/s1
  • InChiKey: IIMATRSRJBJRIX-YTKMXQJZSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 0.0022 0.0074 0.0074
Leishmania major cytochrome p450-like protein 0.0022 0.0074 0.1749
Leishmania major aldehyde dehydrogenase, mitochondrial precursor 0.007 0.0421 1
Brugia malayi Cytochrome P450 family protein 0.0022 0.0074 1
Schistosoma mansoni aldehyde dehydrogenase 0.007 0.0421 1
Toxoplasma gondii pantoate-beta-alanine ligase 0.1394 1 1
Schistosoma mansoni aldehyde dehydrogenase 0.007 0.0421 1
Loa Loa (eye worm) cytochrome P450 family protein 0.0022 0.0074 1
Loa Loa (eye worm) CYP4Cod1 0.0022 0.0074 1
Mycobacterium tuberculosis Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) 0.1394 1 1
Echinococcus multilocularis aldehyde dehydrogenase, mitochondrial 0.007 0.0421 1
Trypanosoma cruzi cytochrome P450, putative 0.0022 0.0074 1
Trypanosoma cruzi cytochrome P450, putative 0.0022 0.0074 1
Echinococcus granulosus aldehyde dehydrogenase mitochondrial 0.007 0.0421 1
Loa Loa (eye worm) cytochrome P450 family protein 0.0022 0.0074 1
Brugia malayi Cytochrome P450 family protein 0.0022 0.0074 1
Mycobacterium ulcerans aldehyde dehydrogenase 0.007 0.0421 0.0421
Mycobacterium tuberculosis Probable aldehyde dehydrogenase 0.007 0.0421 0.0421
Toxoplasma gondii aldehyde dehydrogenase 0.007 0.0421 0.0421
Mycobacterium ulcerans aldehyde dehydrogenase 0.007 0.0421 0.0421
Mycobacterium ulcerans aldehyde dehydrogenase 0.007 0.0421 0.0421
Trypanosoma brucei cytochrome P450, putative 0.0022 0.0074 1
Mycobacterium ulcerans pantoate--beta-alanine ligase 0.1394 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) > 1000 uM Compound was tested for inhibition of MAdCAM-1/alpha4 beta7 mediated cell adhesion to T-cell lymphoma, HUT78 cells ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.